Jennifer Mcmahon
Partner at Seroba
Ireland
Overview
Work Experience
Partner
2021 - Current
Principal
2019 - 2021
Associate
2016 - 2019
Senior Investment Analyst
2014 - 2016
Investment Analyst
2011 - 2014
Seroba Life Sciences is a Venture Capital fund that invests in innovative, European, life science companies. We invest in early-stage start-ups through to the more mature, development-stage bioscience and medical device companies
Member Board of Directors
2022
International Chair
2021
International Chair and Board Observer at Level 20
Board Member
2021
Palliare is a manufacturer of surgical smoke evacuation and insufflation technologies.
Raised $8,000,000.00 from Seroba Life Sciences, SCM AD Ventures and Western Development Commission.
Committee Member
2019
Committee Member
2019
Board Observer
2020
Member Board Of Directors
2016
Endotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before.
Raised $129,596,339.00 from SV Health Investors, Lumira Ventures, Aperture Venture Partners, Wanxiang America Healthcare Investments Group, OSF Ventures, Bioventures Investors, EQT Life Sciences, Skydeck and Seroba Life Sciences.
Board Observer
2017 - 2019
Member Board Of Directors
2015 - 2018
Business Development Advisor
2011 - 2011
As part of my MSc. Biotechnology & Business (Michael Smurfit Business School), I carried out an extensive feasibility analysis and subsequent Business Plan (2011-2014) development for a novel UCD spin-out company (Phision Therapeutics). This process involved an in-depth analysis of the ophthalmic market place in light of the anti-angiogenic compounds that are being developed by Phision Therapeutics and the formulation of an approriate business plan to suit the current market dynamics.
Post-Graduate Student: MSc. Biotechnology & Business at UCD.
2010 - 2011
Education
Chartered Director Programme
2019 - 2020
MSc
2010 - 2011
BSc.
2006 - 2011